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A B S T R A C T
The chief purpose of this work was to synthesise and find out the anti-oxidant and anti-
microbial activities of novel 3-(2-substituted)-1H-indol-3-yl)-1-(thiophen-2yl)prop-2-en-1-
one chalcone derivatives. These derivatives were prepared by performing Claisen–Schmidt
condensation reaction of 1-(thiophen-2yl)ethanone and 2 substituted 1H-indole-3-
carbaldehyde with constant stirring (approximately for 3 hours) in the presence of ethanol
and potassium hydroxide. The newly synthesised compounds’ anti-oxidant and anti-
microbial activities have been identified by using DPPH radical scavenging assay, zone of
inhibition and minimum inhibitory concentration. Most of the prepared compounds had
shown excellent anti-oxidant and anti-microbial activities as compared to the standard drugs
like Ascorbic acid, Ciprofloxacin and Fluconazole. Among the synthesised compounds, com-
pounds 4e, 4h and 4a showed remarkable activity at low concentration. Therefore, these
compounds deserve further research.
© 2016 Beni-Suef University. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Keywords:
Chalcone
Claisen–Schmidt condensation
DPPH assay
Minimum inhibitory concentration
(MIC)
Zone of inhibition
1. Introduction
Chalcones are a unique category of naturally occurring plants
that belong to a class of flavonoids and isoflavonoids that are
mainly present in soy, vegetables, fruit and tea etc. (Maria et al.,
2008). Structurally chalcones are biphenyl compound (1,3-
diphenyl-2-propene-1-one), in which two phenyl rings are
connected by αβ unsaturated carbonyl carbon (Salman et al.,
2015). They are widely distributed in many plants as a sec-
ondary metabolite (Ahmed et al., 2015) and are responsible for
different biological activities such as antiviral, anti-cancer,
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trypanocidal, anti-inflammatory, analgesic, anti-malarial, an-
timicrobial, anti-oxidant, anti-leishmania, anti-tubercular, and
anti-proliferative activities (Ahmed et al., 2014; Barakat et al.,
2015; Gomez-Rivera et al., 2013; Khan et al., 2013; Lin et al., 2002;
Prasad et al., 2008; Sharma et al., 2011; Wu et al., 2002). There-
fore, preparation of novel chalcone is essential for the better
treatment of chronic diseases. Commonly, chalcone and their
derivatives were prepared by conducting the reaction between
an aromatic ketone and aldehyde under a basic environ-
ment, known as Claisen–Schmidt reaction (Venkatachalam et al.,
2012).They served as an intermediate in some heterocyclic com-
pound preparation and are directly used as therapeutic agents.
These derivatives are exhibiting excellent activity and have been
reported in many kinds of literature. Due to its high thera-
peutic profile of chalcone and its derivatives many researchers
had been found various chalcones and their biological activ-
ity. Aforesaid benefit prompted us to prepare a novel 3-(2-
substituted)-1H-indol-3-yl)-1-(thiophen-2yl)prop-2-en-1-one
chalcone, which may exhibit better anti-oxidant and anti-
microbial activities in DPPH radical scavenging assay, zone of
inhibition and minimum inhibitory concentration. The
synthesised compound structures were characterised by FT-
IR, 1HNMR, mass spectroscopy and elemental analysis. Reports
of anti-oxidant and anti-microbial activities stated that many
of the synthesised compounds exhibited significant activity
similar to that of standard drugs.
2. Materials and methods
The materials used in this work were purchased from Alrich,
Ranbaxy and Sigma companies and all are of analytical grade.
Melting point was identified through open capillary tube
method. Each intermediate obtained from various steps and
synthesised compounds were confirmed by TLC using station-
ary phase (silica gel) and mobile phase (the mixture of ethyl
acetate and n-hexane). Functional group present in the
synthesised compound was identified through FT-IR spectros-
copy in the range of 4000 cm−1 to 400 cm−1. 1H-NMR (Brucker
spectrophotometer) has been used to find out the number of
protons present in the synthesised compounds from chemi-
cal shift (δ) and mass of the compound was analysed by
Shimadzu mass spectrometer.
3. Experimental part
3.1. Preparation of 1-(thiophen 2yl)ethanone
A mixture of thiophene (10 g) and acetic anhydride (10 ml) was
placed in phosphoric acid (25 ml) contained beaker. The re-
sulting solution was magnetically stirred for 30 minutes and
then refluxed for 4 hours by a reflux condenser with con-
stant stirring. After completion of the heating process, the
mixture was cooled to room temperature and the oil layer was
removed by washing with 10% sodium carbonate solution. A
precipitate thus obtained was filtered, washed with running
water, dried over anhydrous calcium chloride and recrystallised
from hot ethanol (Khan et al., 2013).
3.2. Preparation of 1H-indole-3-carbaldehyde
An equimolar mixture of indole, N,N-dimethyl formamide and
phosphorous oxychloride (8.75 ml) was poured into the flat
bottom flask at 0 °C.The above-stated mixture was stirred mag-
netically for 5 hours at 60 °C and poured into 10% sodium
carbonate solution (25 ml). After complete addition, the mixture
again stirred for 2 hours at 100 °C.The precipitated product was
extracted with chloroform, washed with water, dried over an-
hydrous calcium chloride and recrystallised from hot ethanol
(Heda et al., 2009).
3.3. Preparation of 2 substituted 1H-indole-3-
carbaldehyde derivatives
1H-indole-3-carbaldehyde and different electrophilic re-
agents were heated under reflux for an appropriate time and
the progression of the reaction was monitored by TLC using
a solvent system of ethyl acetate and n-hexane as a mobile
phase. After completion of the reaction, the hot solution was
transferred into ice cold water. The crude product was formed
as a crystal and recrystallised from hot ethanol. In each reac-
tion, the electrophile (E+) from electrophilic reagent was
connected at the C2 position of the indole and formed differ-
ent 2-substituted 1H-indole-3-carbaldehyde derivatives (3a-h)
(Salman et al., 2015).
3.4. Preparation of 1H-indol-3-yl)-1-(thiophen-2yl)prop-
2-ene-1-one chalcone derivative: general procedure (4a-h)
1-(Thiophen 2yl)ethanone and 2 substituted 1H-indole-3-
carbaldehyde derivatives (aromatic) were mixed together in dry
ethyl alcohol contained 10% potassium hydroxide (20 ml). The
mixture was stirred magnetically for 7 hours at room tem-
perature.The progression of the reaction was monitored by TLC
using the mixture of ethyl acetate and n-hexane as a mobile
phase. After completion of the reaction, the resulting solu-
tion was poured into ice-cold water.The product was separated
as a solid mass, washed with running water, dried over an-
hydrous calcium chloride and recrystallised from hot ethanol
(Rai et al., 2015) (Synthetic scheme).
3.4.1. Preparation of 3-(2-nitro-1H-indol-3-yl)-1-(thiophen-2-
yl)prop-2-en-1-one: (4a)
Molecular formula – C15H10N2O3S; Yield (63%); M.P. – 138 °C; IR
(νmax/cm–1): 3012 (Ar—H str), 1525 (Ar—H ben), 1327 (NO2),
1613(C—C) 1677(C—O); NMR in CDCl3(δ,ppm) – δ6.24–6.45
(d,1H,CH—H, J = 4.8 Hz), δ7.08–7.14(s,4H,Ar—H), δ7.24–7.42
(t,1H,Ar—H, J = 8.5 Hz), δ7.48–7.61(d,1H,CH—H, J = 3.5 Hz),
δ7.79–8.01(m,2H,Ar—H), δ10.15–10.18(s,1H,NH—H); Mass (m/z)
– 298 (42) [M+], 268(42), 252(36), 137 (100), 46 (57), 30 (42);
Element analysis (%) – C(54.11), H(3.32), N(4.25), O(19.24) and
S(19.04).
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3.4.2. Preparation of 3-(3-oxo-3-(thiophen-2-yl)prop-1-enyl)-
1H-indole-2-sulphonic acid: (4b)
Molecular formula – C15H11NO4S2; Yield (75%); M.P. – 157 °C; IR
(νmax/cm–1): 3092 (Ar—H str), 1541(Ar—H ben), 1344 and
1152 (SO3H), 1617(C—C), 1689 (C—O); NMR CDCl3(δ,ppm)
– δ2.10–2.29(s,1H,SO3H—H,), δ6.35–6.42(d,1H,CH—H, J = 7.5 Hz),
δ7.10–7.28(s,4H,Ar—H), δ7.30–7.41(t,1H,Ar—H, J = 8.4 Hz),
δ7.47–7.58(d,1H,CH—H, J = 4.8 Hz), δ7.76–7.92(m,2H,Ar—H),
δ10.10–10.19(s,1H,NH—H); Mass (m/z) – 333(20) [M+], 252(31), 202
(42), 129 (100), 84 (39), 39 (24); Element analysis (%) – C(54.41),
H(3.54), N(4.84), O(19.23) and S(19.01).
3.4.3. Preparation of 3-(2-methyl-1H-indol-3-yl)-1-(thiophen-
2yl)prop-2-en-1-one: (4c)
Molecular formula – C16H13NOS; Yield (67%); M.P. – 144 °C; IR
(νmax/cm–1): 3042 (Ar—H str), 1531 (Ar—H ben), 1618 (C—C),
1665(C—O); NMR CDCl3(δ,ppm) – δ2.25–2.29(s,3H, CH3—H),
δ6.23–6.30 (d,1H,CH—H, J = 7.5 Hz), δ6.40–6.61(d,1H,Ar—H,
J = 8 Hz), δ6.64–6.78(d,1H,Ar—H, J = 3.2 Hz), δ7.03–7.15
(m,3H,Ar—H), δ7.34–7.43(d,1H,CH—H, J = 8.5 Hz), δ7.64–7.76
(m,2H,Ar—H), δ10.22–10.24(S,1H,NH—H); Mass (m/z) – 267 (30)
[M+], 266(20), 239(25), 192(29), 124(100), 64(22), 39 (52); Element
analysis (%) – C(71.43), H(4.64), N(5.59), O(5.53) and S(11.05).
3.4.4. Preparation of 3-(2-ethyl-1H-indol-3-yl)-1-(thiophen-
2yl)prop-2-en-1-one: (4d)
Molecular formula – C17H15NOS; Yield (59%); M.P. – 175 °C; IR
(νmax/cm–1): 3025(Ar—H str), 1511(Ar—H ben), 1616 (C—C),
1672(C—O); NMR CDCl3(δ,ppm) – δ1.35–1.52(t,3H, CH3-H, J = 7 Hz),
δ2.42–2.68(q,2H, CH2-H, J = 12 Hz), δ6.22–6.43 (d,1H,CH—H,
J = 3.4 Hz), δ6.45–6.61(d,1H,Ar—H, J = 8.5 Hz), δ6.72–6.81
(d,1H,Ar—H, J = 3.2 Hz), δ6.93–7.21(m,3H,Ar—H), δ7. 26-7.40
(d,1H,CH—H, J = 4.2 Hz), δ7.72–7.85(q,2H,Ar—H, J = 12 Hz),
δ10.33–10.39(S,1H,NH—H); Mass (m/z) – 281 (47) [M+], 266(39),
198(55), 124(100), 79(47), 26(38); Element analysis (%) – C(72.02),
H(5.25), N(4.16), O(5.47) and S(11.27).
3.4.5. Preparation of 3-(2-chloro-1H-indol-3-yl)-1-(thiophen-
2yl)prop-2-en-1-one: (4e)
Molecular formula – C15H10ClNOS; Yield (58%); M.P. – 162 °C; IR
(νmax/cm–1): 3028 (Ar—H str), 1545 (Ar—H ben), 1621 (C—C),
1669(C—O), 753(Cl); NMR CDCl3(δ,ppm) – δ6.55–6.68(d,1H,CH—H,
J = 3.8 Hz), δ7.02–7.07(s,4H,Ar—H), δ7.20–7.29(t,1H,Ar—H,
J = 7.5 Hz), δ7.36–7.52(d,1H,CH—H, J = 4.2 Hz), δ7.53–7.80
(m,2H,Ar—H), δ10.30–10.43(s,1H,NH—H); Mass (m/z) – 287(48)
[M+], 289(16) [M++2], 222(20), 123(46), 97(37), 61(100); Element
analysis (%) – C(62.25), H(3.06), N(4.03), O(5.30), Cl(12.61) and
S(11.11).
3.4.6. Preparation of 3-(2-bromo-1H-indol-3-yl)-1-(thiophen-
2yl)prop-2-en-1-one: (4f)
Molecular formula – C15H10BrNOS; Yield (72%); M.P. – 193 °C; IR
(νmax/cm–1): 3101 (Ar—H str), 1540 (Ar—H ben), 1612(C—C),
1710(C—O), 612(Br); NMR CDCl3(δ,ppm) – δ6.32–6.51(d,1H,CH—H,
J = 3.2 Hz), δ6.90–7.02(s,4H,Ar—H), δ7.12–7.28(t,1H,Ar—H,
J = 7.4 Hz), δ7.38–7.54(d,1H,CH—H, J = 4.2 Hz), δ7.65–7.87
(q,2H,Ar—H, J = 12 Hz), δ10.06–10.12(S,1H,NH—H); Mass (m/z)
– 332(44) [M+], 334(46) [M++2], 252(28), 222(35), 129(51), 79(100);
Element analysis (%) – C(54.25), H(3.06), N(4.16), O(4.15), Br(24.31)
and S(9.02).
3.4.7. Preparation of 3-(2-iodo-1H-indol-3-yl)-1-(thiophen-
2yl)prop-2-en-1-one: (4g)
Molecular formula – C15H10INOS; Yield (58%); M.P. – 162 °C; IR
(νmax/cm–1): 3089 (Ar—H str), 1503(Ar—H ben), 1625 (C—C),
1681(C—O), 532(I); NMR CDCl3(δ,ppm) – δ6.25–6.43(d,1H,CH—H,
J = 3.8 Hz), δ6.82–6.95(s,4H,Ar—H), δ7.19–7.29(t,1H,Ar—H,
J = 7.5 Hz), δ7.47–7.56(d,1H,CH—H, J = 7.0 Hz), δ7.72–7.96
(q,2H,Ar—H), δ10.12–10.18(s,1H,NH—H); Mass (m/z) – 379(39) [M+],
289(28), 222(20), 123(47), 97(33), 61(100); Element analysis
(%) – C(47.53), H(2.42), N(3.21), O(4.11), I(33.10) and S(8.13).
3.4.8. Preparation of 3-(2-chloromethyl)-1H-indol-3-yl)-1-
(thiophen-2yl)prop-2-en-1-one: (4h)
Molecular formula – C15H12ClNOS; Yield (88%); M.P. – 179 °C; IR
(νmax/cm–1): 3015 (Ar—H str), 1525 (Ar—H ben), 1616 (C—C),
1675(C—O), 738(Cl); NMR CDCl3(δ,ppm) – δ4.65–4.71(s,2H,CH2—H),
δ6.14–6.33(d,1H,CH—H, J = 7.0 Hz), δ6.55–6.73(d,1H,Ar—H,
J = 4.2 Hz), δ6.78–6.89(d,1H,Ar—H, J = 3.8 Hz), δ6.93–7.10
(m,3H,Ar—H), δ7.42–7.56(d,1H, CH—H, J = 5.4 Hz), δ7.64–7.95
(m,2H,Ar—H), δ10.34–10.45(s,1H,NH—H); Mass (m/z) – 301(45)
[M+], 303(18) [M++2], 225(51), 110(29), 76(100); Element analysis
(%) – C(63.04), H(4.16), N(4.25), O(5.56), Cl(11.24), and S(10.03).
4. In-vitro biological activity
4.1. DPPH scavenging method
Anti-oxidant activity of novel 3-(2- substituted)-1H-indol-3-
yl)-1-(thiophen-2yl)prop-2-en-1-one chalcone derivatives was
assessed by using DPPH method (Chidankumar et al., 2013).
It is an ideal and convenient method to assess the antioxi-
dant activity of novel compounds. DPPH is an unstable free
radical that gets maximum absorbance at 517 nm due to the
presence of an odd electron, which disappears when paired
with an antioxidant or reducing agent. An antioxidant or re-
ducing agent may supply electron or hydrogen to the DPPH free
radical and bleach the colour of the DPPH solution. Generally,
2,2 diphenyl 1 picrylhydrazyl has produced a black purple colour
in methanol, it becomes colourless or yellow in colour when
paired with an electron and turns to 2,2 diphenyl 1 picryl hy-
drazine (Fig. 1).
4.2. Paper disc diffusion technique
Anti-bacterial and anti-fungal activities of synthesised com-
pounds were assessed by paper disc diffusion method (Gopi
et al., 2015). Here, all the synthesised compounds’ anti-
microbial activities were calculated from the zone of inhibition
in Mueller–Hinton (anti-bacterial) and Sabouraud dextrose
culture media (antifungal). First, the aforesaid sterilised (120 °C
for 30 min in autoclave) culture medium (40–50 °C) was pre-
pared and poured into a Petri dish (3–4 mm), solidifed and
seeded with different micro-organisms (Staphylococcus aureus
(ATCC-9144), Escherichia coli (ATCC-25922), Staphylococcus
epidermidis (ATCC-155), Pseudomonas aeruginosa (ATCC-2853),
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Aspergillus fumigatus (ATCC-46645), Aspergillus niger (ATCC-
9029)) in a each plate. Simultaneously, different dilutions of
synthesised compounds (50 µg and 100 µg) and standard so-
lutions were prepared in dimethylformamide (DMF).To identify
the anti-microbial activities, the paper impregnated synthesised
compounds (50 µg and 100 µg) were placed on the solidified
Mueller–Hinton/Sabouraud dextrose medium and incubated at
37 °C for 24 hours/48 hours. In addition to that, Ciprofloxacin
(100 mg/disc) and Fluconazole (100 mg/disc) were also placed
on the Petri dish and had been considered as a standard for
antibacterial and antifungal activities respectively. The solvent
control was charged separately on a Petri dish. Each com-
pound anti-microbial activity has been measured from its zone
of inhibition against standard drugs.
4.3. Minimum inhibitory concentration
Minimum inhibitory concentration (MIC) is the least concen-
tration of an antimicrobial agent having the potency to inhibit
the detectable growth of a microorganism after an overnight
period of incubation in appropriate culture media (Alagarsamy
et al., 2015; Lambert et al., 2001). It is used to detect the potency
and drug resistance nature of anti-microbial agents. A highly
potent anti-microbial agent had the least value of MIC and
needed less quantity to inhibit the visible growth of the micro-
organism. An anti-microbial agent that is called as less active
needs high concentration to kill the micro-organism and to have
greater MIC value. Here, the anti-microbial activities of differ-
ent concentrations of the synthesised compounds in
dimethylformamide (DMF) were calculated through MIC value.
Each concentration of the synthesised compounds (1, 2, 4, 16,
32, 64, 128 and 256 µg/ml) was tested with bacteria/fungal
seeded culture medium (Mueller–Hinton and Sabouraud dex-
trose) for 24 hours/48 hours at 37 °C.
5. Result and discussion
5.1. Chemistry
The entire synthesised compounds were prepared from the
mentioned synthetic scheme that is depicted in Scheme 1. The
novel bi-heterocyclic chalcone derivatives were prepared by a
Claisen–Schmidt condensation reaction between 1-(thiophen
2yl)ethanone and 2 substituted 1H-indole-3-carbaldehyde (4a-h).
Each synthesised compound structure was elucidated by FT-
IR, 1HNMR, mass spectroscopy and element analysis. Fourier
transform infrared spectroscopy has been showing peaks due
to the presence of different functional groups in the synthesised
compounds.The strong bands at the regions of 1327, 1344, 1152,
753, 738, 612 and 532 cm−1 could be attributed to the pres-
ence of NO2, SO3H, Cl, Br, and Iodo groups respectively. The aryl
stretching peak was found between 3101 and 3012 cm−1 and
the bending peak was found at the region of 1503–1545 cm−1.
The number of protons present in the synthesised com-
pounds was identified by 1H-NMR spectroscopy from the
chemical shift (δ in ppm). The spectra showed a singlet at
δ2.10–2.29 ppm corresponding to sulphonic acid proton (-SO3H);
a doublet at δ 6.14–7.61 ppm corresponding to αβ unsatu-
rated carbon proton (H—C—C—H); a singlet at δ 2.25–2.29 ppm
to methyl (-CH3-H); a singlet at δ 4.65–4.71 ppm correspond-
ing to methylene bridge (-CH2-H); a singlet at δ 6.82–7.28 ppm
corresponding to aromatic protons (Ar—H); a doublet at
δ 6.40–6.89 ppm corresponding to aromatic protons (Ar—H); a
triplet at δ 7.19–7.42 ppm corresponding to aromatic protons
(Ar—H); a quartet at δ 7.65–7.96 ppm corresponding to
aromatic protons (Ar—H); a multiplet at δ 6.93–7.95 ppm
corresponding to aromatic protons (Ar—H) and a singlet at δ
10.06–10.45 ppm corresponding to NH-proton. The synthesised
compounds’ molecular mass was confirmed by Shimadzu mass
spectrometer and composition of the atom present in the
synthesised compounds was confirmed through element
analysis.
5.2. Anti-oxidant activity
The entire synthesised compound had been prepared
(100 µg/ml) by dissolving in methanol. Then the prepared con-
centration of each test solution (4 ml) was added to 4 ml of DPPH
(100 µg/ml) in methanol solution and the content was left for
30 minutes at room temperature. Absorbance was measured
at 517 nm for 10 minutes using Shimadzu ultraviolet spec-
trometer against the standard and blank samples. Ascorbic acid
was employed as a standard drug to screen the antioxidant
activity of each test compound. A test tube containing blank
solution was also prepared devoid of test and standard com-
pound. Each synthesised compound antioxidant activity was
calculated from the percentage radical scavenging activities by
substituting the absorbance value in the mentioned formula.
On the whole, compound 4e had shown an almost similar per-
centage scavenging activity (59.49) as that of a standard drug
N
N
O2N
O2N
H
2,2-diphenyl-1- picrylhydrazyl
N
H
N
O2N
O2N
2,2-diphenyl-1-picrylhydrazine
NO2NO2
Fig. 1 – DPPH colour disappears after interacting with anti-oxidant.
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(62.92). The percentage scavenging activity of the synthesised
compound was compared to the standard drug as shown in
Table 1 and Fig. 2.
Percentage inhibition
Absorbance of blank Absorbance of te
=
− st
Absorbance of blank
∗100
5.3. Anti-microbial activity
In the recent times, many organisms are developing resis-
tance to available antibiotics. Therefore, there is a need to
prepare a novel agent that is resistant free in nature, acts
specifically on micro-organisms and causes the least harm to
the host function. The synthesised chalcone derivatives pos-
sessed all the advantages as stated above due to the presence
of thiazole and indole nucleus as part of the molecular struc-
ture. All the synthesised compounds (4a-4h) had been screened
for anti-microbial activity against S. aureus (ATCC-9144), E. coli
(ATCC-25922), P. aeruginosa (ATCC-2853), S. epidermidis (ATCC-
155), A. fumigatus (ATCC-46645) and A. niger (ATCC-9029) using
zone of inhibition (mm) and minimum inhibitory concentra-
tion (µg/ml) level. We found that many of the synthesised
compounds showed significant anti-microbial activity against
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E = CH2ClE = Cl, Br, I
E = CH3,C2H5E = NO2,SO3H [4 c-d][4 a-b] [4e-g] [4h]
[2]
[1] [1] [1] [1]7 hours stirring 7 hours stirring 7 hours stirring 7 hours stirring
Scheme 1 – Synthetic protocol for various potent chalcone derivatives 4a-h.
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different organisms and the results are demonstrated in Tables 2
and 3. Among the different synthesised compounds, com-
pounds 4e, 4h and 4a showed significant anti-microbial activity
against various organisms as compared to standard drugs like
Ciprofloxacin and Fluconazole. Particularly compound 4e had
shown the highest zone of inhibition against S. epidermidis
(30 µg/ml), S. aureus (27 µg/ml), P. aeruginosa (27 µg/ml), E. coli
(32 µg/ml), A. fumigatus (20 µg/ml), and A. niger (21 µg/ml) and
the lowest MIC value for S. epidermidis (03 µg/ml), S. aureus
(08 µg/ml), P. aeruginosa (04 µg/ml), E. coli (08 µg/ml), A. fumigatus
(04 µg/ml) and A. niger (08 µg/ml). Therefore, the further study
of 4e, 4h and 4a is required to make an effective and resis-
tant free anti-microbial agent. The comparison of the zone of
inhibition and minimum inhibitory of the synthesised com-
pounds is shown in Figs. 3 and 4.
6. Conclusion
This study stated that a cheap and easy way of synthesis of 3
novel 3-(2-substituted)-1H-indol-3-yl)-1-(thiophen-2yl)prop-2-
en-1-one chalcone derivatives from 1-(thiophen-2yl)ethanone
and 2 substituted 1H-indole-3-carbaldehyde and their biologi-
cal activity. Compounds 4e, 4h and 4a had shown excellent anti-
oxidant and anti-microbial activities by DPPH radical scavenging
assay, the zone of inhibition and minimum inhibitory concen-
tration. Compound 4e had shown admirable anti-oxidant and
anti-microbial activities similar to those of a standard drug.
The results suggested that many synthesised molecules act as
an excellent electron donor (resonance effect) and are highly
lipophilic in nature due to the presence of a Cl, NO2 and Br
Table 1 – Result of anti-oxidant activity of synthesised
compounds with percentage scavenging.
S. no. Compounds Absorbance
(mean ± standard
deviation at 517 nm)
Percentage
scavenging
1 4a 0.461 ± 0.004* 47.25
2 4b 0.721 ± 0.006* 17.50
3 4c 0.532 ± 0.003* 39.13
4 4d 0.586 ± 0.004* 32.95
5 4e 0.354 ± 0.005* 59.49
6 4f 0.752 ± 0.002* 13.95
7 4g 0.614 ± 0.005* 29.7
8 4h 0.381 ± 0.006* 56.40
10 Blank 0.874 ± 0.002 NA
9 Ascorbic acid 0.324 ± 0.001* 62.92
* P < 0.001as compared to blank and standard respectively.
Statistical analysis – one way ANOVA.
NA – not applicable and NS – not significant.
Fig. 2 – Percentage scavenging activity of synthesised compounds against standard drug.
Table 2 – Zone of inhibition of synthesised compounds against different micro-organisms (mm).
Compounds S. epidermidis S. aureus P. aeruginosa E. coli A. fumigates A. niger
4a 28 25 24 25 18 17
4b 22 21 20 19 14 14
4c 18 14 15 14 10 10
4d 15 15 12 13 10 11
4e 30 27 27 32 20 21
4f 24 23 22 25 16 15
4g 24 22 20 22 15 14
4h 28 25 27 28 19 19
Ciprofloxacin 31 29 32 32 – –
Fluconazole – – – – 21 22
Control 01 – – 01 – –
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committed to the indole ring. Therefore, consider 4e, 4h and
4a as reference molecules to prepare a potent anti-oxidant and
anti-microbial agent in the future.
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Table 3 – Minimum inhibitory concentration of synthesis compounds against different micro-organisms (µg/ml).
Compounds S. epidermidis S. aureus P. aeruginosa E. coli A. fumigates A. niger
4a 08 08 16 16 04 32
4b 64 128 64 6 64 32
4c 128 128 64 32 64 64
4d 128 128 64 32 64 64
4e 03 08 04 08 04 08
4f 16 16 08 64 32 32
4g 16 32 32 08 64 64
4h 08 04 16 16 08 16
Ciprofloxacin 02 02 01 02 – –
Fluconazole – – – – 02 01
Fig. 3 – Anti-bacterial and anti-fungal zone of inhibition (mm) of synthesised compounds against standard drug.
Fig. 4 – Anti-bacterial and anti-fungal minimum inhibitory concentration (µg/ml) of synthesised compounds against
standard drug.
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